Treatment of childhood acute lymphoblastic leukemia in central America: A lower‐middle income countries experience

Abstract

This experience shows that common international studies are feasible in lower-middle income countries. Toxic deaths, abandonment of treatment, and relapses remain major obstacles to the successful treatment. Alternative treatment strategies may be beneficial.